Is QUBT a Buy or a Sell? The Bull and Bear Case (2026)

That depends on which case you find more convincing, and both are on this page. The bull case rests on Photonics-first quantum approach, with revenue (ttm) at ~$9.8 million (Q2 2026 was ~$5.55 million). The bear case rests on the bear case is that valuation is still disconnected from fundamentals: trailing revenue is about $10 million against a market value near $1.5 billion, implying a price-to-sales ratio near 150. Analysts covering it are spread from $10.00 to $32.00, which is itself a signal that this is genuinely contested. If you believe the thesis, the real questions become sizing and overlap rather than timing. Walnut is not an investment adviser and this is not a recommendation.

Nobody can answer that for you, and the honest version of the question is narrower: has anything changed in the reason you bought it? The bear case on this page is the place to check. The bear case is that valuation is still disconnected from fundamentals: trailing revenue is about $10 million against a market value near $1.5 billion, implying a price-to-sales ratio near 150. If that risk is what you were worried about and it is now playing out, that is a real signal. If the price simply fell while the thesis held, that is a different situation entirely. The most pessimistic published target is $10.00, +57.2% from the $6.36 price, which is one analyst's downside case rather than a floor. Walnut is not an investment adviser.

Photonics-first quantum approach. QCi's machines move light through engineered TFLN chips rather than relying on supercooled superconducting circuits. The most optimistic analyst target on QUBT is $32.00, +403.1% from the $6.36 price. That figure is only reachable if this thesis works close to its best case.

The bear case is that valuation is still disconnected from fundamentals: trailing revenue is about $10 million against a market value near $1.5 billion, implying a price-to-sales ratio near 150. The company is unprofitable with negative gross margins (about -19% TTM) and an operating loss far larger than revenue, the Q2 2026 net loss nearly tripled from Q1, and the cash hoard was built through dilutive share issuance that can continue. Analysts expect losses to persist through 2027. The stock is extremely volatile, with a 52-week range of roughly $6 to $19 and a decline of about 66% over the past year, and it tends to move on quantum-sector sentiment and retail momentum rather than results, so sharp drawdowns are common. The most pessimistic published target is $10.00, +57.2% from the current price, which is roughly what the stock is worth if these risks bite rather than the drivers.

Quantum Computing Inc., an integrated photonics company, provides quantum machines to commercial and government markets in the United States.

Decide that in advance, because it is far harder to think clearly once a position is moving against you. The concrete tripwires here: the driver behind the bull case (Photonics-first quantum approach) stalling in the reported numbers rather than in the narrative, the risk above (the bear case is that valuation is still disconnected from fundamentals: trailing revenue is about $10 million against a market value near $1.5 billion, implying a price-to-sales ratio near 150) turning from a possibility into a reported fact, or the position growing large enough that a bad outcome would matter to your whole portfolio regardless of who is right.

QCi is an integrated photonics and quantum optics company. It designs photonic quantum machines, including its entropy quantum computer (the Dirac) for optimization problems, and makes thin-film lithium niobate (TFLN) photonic chips for itself and outside customers through a foundry. It targets commercial and government markets and is building out fabrication capacity.

QUBT does build real quantum and photonics hardware, including its Dirac entropy quantum computer and TFLN chips, and has won contracts tied to bodies like NIST plus a 2026 research partnership with INmune Bio. That said, it is early-stage and pre-commercial: trailing revenue is about $10 million, so the business is far from proven at scale.

Walnut is not an investment adviser and cannot tell you whether to buy. Objectively, QUBT is a highly speculative quantum play with about $10 million of trailing revenue and a market value near $1.5 billion as of October 2026, so it trades on expectations and sentiment. Whether it fits depends on your goals, risk tolerance, and how much speculative exposure you already hold.